2 London Mempool companies backed by LifeArc Ventures
Rank =208 of 430 on the investor leaderboard. No source we have says it led a round in any of them.
See them on the mapCounts only deals named in a source we fetched
- Health2
Portfolio on the map (2)
Develops multispecific antibodies that engage gamma delta T cells to treat solid tumour cancers.
Health · Immuno-oncology · Fastest growingsource: cytospire.comBiotech developing long-acting monoclonal antibodies to prevent seasonal flu and other respiratory viruses.
Health · Antibody Therapeutics · Fastest growingsource: uk.finance.yahoo.com
We list LifeArc Ventures on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count